Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting3
Not Yet Recruiting1

Clinical Trials (4)

Showing 4 of 4 trials
NCT07442760RecruitingPrimary

ePro Diary - HDV ( MACROLIVER )

NCT06160635RecruitingPrimary

D-SOLVE Cohorts (Cohort a and B)

NCT06834178Not Yet Recruiting

Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria

NCT05350865RecruitingPrimary

Thailand HDV Cohort

Showing all 4 trials

Research Network

Activity Timeline